Latest News
- January 08, 2026Official press release: CBCC Global Research is now REV Clinical
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
April 21, 2022
Exhibit Booth Sponsor at DIA 2022
CBCC Global Research is Exhibit Booth Sponsor at the DIA 2022 Global Annual Meeting
Stop by our booth #2431 to forge new partnerships!
This summit will be held on 19-23 June 2022 in Chicago, IL.
For more details, please visit: https://www.diaglobal.org/Flagship/DIA-2022